Concepedia

Author

Michaela A.E. Arndt

Heidelberg University

Also Known As

M A E Arndt, M Arndt, M. A. E. Arndt, M. A.E. Arndt, Michaela A E Arndt, Michaela A. E Arndt, Michaela A. E. Arndt, Michaela A.E. Arndt, Michaela AE Arndt, Michaela Arndt

31

Publications

672

Citations

16

H-Index

30

Concepts

All Affiliations

Heidelberg UniversityNational Center for Tumor DiseasesUniversity Hospital HeidelbergNational Cancer InstituteGerman Cancer Research Center
MA

About

Michaela A.E. Arndt is an author at Heidelberg University specializing in immunology, medicine, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

216

2

Cell Biology

4

4

93

3

Engineering

1

1

15

4

Allergy

1

1

15

5

Biomolecular Engineering

1

1

11

Michaela A.E. Arndt

×

18

Publications

573

Citations

15

H-Index

YearCitations

Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody

Adalbert Krawczyk, Michaela A.E. Arndt, Ludger Große‐Hovest,

Proceedings of the National Academy of Sciences

2013

88

A Bispecific Diabody That Mediates Natural Killer Cell Cytotoxicity Against Xenotransplantated Human Hodgkin’s Tumors

Michaela A.E. Arndt, Sergey M. Kipriyanov, Michael Pfreundschuh,

Blood

1999

84

Impact of Valency of a Glycoprotein B-Specific Monoclonal Antibody on Neutralization of Herpes Simplex Virus

Adalbert Krawczyk, Anna Maria Eis‐Hübinger, Martin Däumer,

Journal of Virology

2010

62

Efficient killing of CD22+ tumor cells by a humanized diabody–RNase fusion protein

Michaela A.E. Arndt, Bang K. Vu, Dianne L. Newton,

Biochemical and Biophysical Research Communications

2005

39

Specificity grafting of human antibody frameworks selected from a phage display library: generation of a highly stable humanized anti-CD22 single-chain Fv fragment

Michaela A.E. Arndt, Andrew C.R. Martin, Haibo Liu,

Protein Engineering Design and Selection

2003

35

Impact of antibody framework residue VH-71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme

Juergen Krauss, Michaela A.E. Arndt, Zhongyu Zhu,

British Journal of Cancer

2004

30

A Dimeric Angiogenin Immunofusion Protein Mediates Selective Toxicity Toward CD22+ Tumor Cells

Michaela A.E. Arndt, Bang K. Vu, Dianne L. Newton,

Journal of Immunotherapy

2005

30

Targeting malignant B‐cell lymphoma with a humanized anti‐CD22 scFv‐angiogenin immunoenzyme‡

Michaela A.E. Arndt, Bang K. Vu, Dianne L. Newton,

British Journal of Haematology

2005

29

Generation of a highly stable, internalizing anti‐CD22 single‐chain Fv fragment for targeting non‐Hodgkin's lymphoma

Michaela A.E. Arndt, Robert Schwarzenbacher, Bang K. Vu,

International Journal of Cancer

2003

27

A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells

Tobias Weber, Athanasios Mavratzas, Stefan Kiesgen,

Journal of Immunology Research

2015

26

Page 1